Inventage Lab (XKRX:389470) Total Liabilities : ₩35,876.6 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Total Liabilities?

Inventage Lab's Total Liabilities for the quarter that ended in Mar. 2024 was ₩35,876.6 Mil.

Inventage Lab's quarterly Total Liabilities declined from Sep. 2023 (₩46,652.50 Mil) to Dec. 2023 (₩40,771.72 Mil) and declined from Dec. 2023 (₩40,771.72 Mil) to Mar. 2024 (₩35,876.59 Mil).

Inventage Lab's annual Total Liabilities declined from Dec. 2021 (₩5,233.09 Mil) to Dec. 2022 (₩4,427.10 Mil) but then increased from Dec. 2022 (₩4,427.10 Mil) to Dec. 2023 (₩40,771.72 Mil).

Inventage Lab Total Liabilities Historical Data

The historical data trend for Inventage Lab's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Total Liabilities Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

41,436.07

5,628.31

5,233.09

4,427.10

40,771.72

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial					3,642.52	23,680.56	46,652.50	40,771.72	35,876.59

Inventage Lab Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Inventage Lab's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	28876.177	+	(6236.167	+	5659.371
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	40,771.7

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	45182.343	-	4410.627
	=	40,771.7

Inventage Lab's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	22886.432	+	(0	+	12990.156
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	35,876.6

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	42806.302	-	6929.715
	=	35,876.6

Inventage Lab Total Liabilities Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines